Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
D015110:4-Hydroxycoumarins / Q000627:therapeutic use*; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D001317:Austria; D001792:Blood Platelets / Q000187:drug effects; D004311:Double-Blind Method; D005069:Evaluation Studies as Topic; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control*; D010644:Phenprocoumon / Q000627:therapeutic use*; D010919:Placebos; D011446:Prospective Studies; D012008:Recurrence; D012306:Risk
D015110:4-Hydroxycoumarins; D010919:Placebos; D010644:Phenprocoumon; D001241:Aspirin